352 filings
S-8
BDTX
Black Diamond Therapeutics Inc
12 Mar 24
Registration of securities for employees
8:01am
10-K
2023 FY
BDTX
Black Diamond Therapeutics Inc
Annual report
12 Mar 24
7:20am
8-K
BDTX
Black Diamond Therapeutics Inc
12 Mar 24
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:17am
SC 13G/A
BDTX
Black Diamond Therapeutics Inc
11 Mar 24
Black Diamond Therapeutics / T. Rowe Price Investment Management ownership change
1:14pm
4
BDTX
Black Diamond Therapeutics Inc
15 Feb 24
Black Diamond Therapeutics / Fang Ni ownership change
5:45pm
4
BDTX
Black Diamond Therapeutics Inc
15 Feb 24
Black Diamond Therapeutics / Brent Hatzis-Schoch ownership change
5:38pm
4
BDTX
Black Diamond Therapeutics Inc
15 Feb 24
Black Diamond Therapeutics / Sergey Yurasov ownership change
5:37pm
4
BDTX
Black Diamond Therapeutics Inc
15 Feb 24
Black Diamond Therapeutics / Elizabeth Buck ownership change
5:36pm
4
BDTX
Black Diamond Therapeutics Inc
15 Feb 24
Black Diamond Therapeutics / Mark A. Velleca ownership change
5:35pm
4
BDTX
Black Diamond Therapeutics Inc
15 Feb 24
Black Diamond Therapeutics / Erika Jones ownership change
5:34pm
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 24
Black Diamond Therapeutics / T. Rowe Price Investment Management ownership change
10:04am
SC 13G/A
BDTX
Black Diamond Therapeutics Inc
13 Feb 24
Black Diamond Therapeutics / BB BIOTECH ownership change
6:05am
8-K
BDTX
Black Diamond Therapeutics Inc
18 Jan 24
Departure of Directors or Certain Officers
4:04pm
8-K
BDTX
Black Diamond Therapeutics Inc
4 Jan 24
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
8:07am
4
Behbahani Ali
15 Dec 23
Black Diamond Therapeutics / Ali Behbahani ownership change
4:48pm
4
Dixon Wendy L
15 Dec 23
Black Diamond Therapeutics / WENDY L DIXON ownership change
4:40pm
8-K
BDTX
Black Diamond Therapeutics Inc
13 Dec 23
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
7:08am
SC 13D/A
Versant Venture Capital VI, L.P.
9 Nov 23
Black Diamond Therapeutics / Versant Venture Capital VI ownership change
5:24pm
8-K
BDTX
Black Diamond Therapeutics Inc
6 Nov 23
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:10am